Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76101 - 76125 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Sulindac	Approved Investigational	KIAA1324L	222223	upregulated	Sulindac results in increased expression of KIAA1324L mRNA	7q21.12	A20927
Sulindac	Approved Investigational	KIF14	9928	upregulated	Sulindac results in increased expression of KIF14 mRNA	1q32.1	A20927
Sulindac	Approved Investigational	KLF5	688	upregulated	Sulindac results in increased expression of KLF5 mRNA	13q22.1	A20927
Sulindac	Approved Investigational	LAD1	3898	upregulated	Sulindac results in increased expression of LAD1 mRNA	1q32.1	A24352
Sulindac	Approved Investigational	LARP4	113251	upregulated	Sulindac results in increased expression of LARP4 mRNA	12q13.12	A20927
Sulindac	Approved Investigational	LDB1	8861	upregulated	Sulindac results in increased expression of LDB1 mRNA	10q24.32	A20927
Sulindac	Approved Investigational	LFNG	3955	upregulated	Sulindac results in increased expression of LFNG mRNA	7p22.3	A20927
Sulindac	Approved Investigational	LOX	4015	downregulated	Sulindac analog results in decreased expression of LOX mRNA	5q23.1	A23447
Sulindac	Approved Investigational	MAP4K3	8491	upregulated	Sulindac results in increased expression of MAP4K3 mRNA	2p22.1	A20927
Sulindac	Approved Investigational	MED15	51586	upregulated	Sulindac results in increased expression of MED15 mRNA	22q11.21	A20927
Sulindac	Approved Investigational	MIIP	60672	upregulated	Sulindac results in increased expression of MIIP mRNA	1p36.22	A20927
Sulindac	Approved Investigational	MTHFD2	10797	upregulated	Sulindac results in increased expression of MTHFD2 mRNA	2p13.1	A20927
Sulindac	Approved Investigational	MYC	4609	upregulated	Sulindac results in increased expression of MYC mRNA	8q24.21	A22363
Sulindac	Approved Investigational	NAP1L1	4673	downregulated	Sulindac results in decreased expression of NAP1L1 mRNA	12q21.1	A24352
Sulindac	Approved Investigational	NAT1	9	downregulated	Sulindac results in decreased expression of NAT1 mRNA	8p22	A24354
Sulindac	Approved Investigational	NDRG1	10397	upregulated	Sulindac results in increased expression of NDRG1 mRNA	8q24.22	A24350
Sulindac	Approved Investigational	NDST2	8509	downregulated	Sulindac results in decreased expression of NDST2 mRNA	10q22.2	A20927
Sulindac	Approved Investigational	NEU1	4758	upregulated	Sulindac results in increased expression of NEU1 mRNA	6p21.33	A20927
Sulindac	Approved Investigational	NFE2L1	4779	upregulated	Sulindac results in increased expression of NFE2L1 mRNA	17q21.3	A20927
Sulindac	Approved Investigational	NFIL3	4783	upregulated	Sulindac results in increased expression of NFIL3 mRNA	9q22.31	A20927
Sulindac	Approved Investigational	NPC1	4864	upregulated	Sulindac results in increased expression of NPC1 mRNA	18q11.2	A20927
Sulindac	Approved Investigational	NQO1	1728	upregulated	Sulindac results in increased expression of NQO1 mRNA	16q22.1	A24351 A24353
Sulindac	Approved Investigational	ORC4	5000	downregulated	Sulindac results in decreased expression of ORC4 mRNA	2q23.1	A20927
Sulindac	Approved Investigational	OSTF1	26578	upregulated	Sulindac results in increased expression of OSTF1 mRNA	9q21.13	A20927
Sulindac	Approved Investigational	OTUD1	220213	upregulated	Sulindac results in increased expression of OTUD1 mRNA	10p12.2	A20927

Displaying entries 76101 - 76125 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability